Glucoerucin potassium salt
| Product Name | Glucoerucin potassium salt |
|---|---|
| Alternate Names | - Carbohydrates, Carbohydrates of - |
| CAT No. | CS-O-49096 |
| CAS No. | 15592-37-7 |
| Category | Carbohydrates |
| Stock | Enquire |
| Mol. Wt. | 460.61 g/mol |
| Mol. For. | C12H23NO9S3.K |
| Hazardous | This is not a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | - |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
Get an Instant Quote
Related Compounds
B-Antigen-Cer d18:1/18:0-Biotin (Gala1,3(Fuca1,2)Galb1,4GlcbCeramide-Biotin) | GM3Cer d20:1/20:0 (Neu5Aca2,3Galb1,4GlcbCeramide) | GD2Cer d18:1/18:0-Biotin (GalNAcb1,4(Neu5Aca2,8Neu5Aca2,3)Galb1,4GlcbCeramide-Biotin) | GM1bCer d18:1/8:0 (Neu5Aca2,3Galb1,3GalNAcb1,4Galb1,4GlcbCeramide) | GD3Cer d20:1/18:0 (Neu5Aca2,8Neu5Aca2,3Galb1,4GlcbCeramide) | GM1asph d20:1 (Galb1,3GalNAcb1,4(Neu5Aca2,3)Galb1,4GlcbSphingolipids) | GlcCer d18:1/20:0 (GlcbCeramide) | GD1bCer d18:1/20:0 (Galb1,3GalNAcb1,4(Neu5Aca2,8Neu5Aca2,3)Galb1,4GlcbCeramide) | Ac7 Lactose-PEG-N3 | GM3Cer d18:1/8:0 (Neu5Aca2,3Galb1,4GlcbCeramide) | Pk(Gala1,4Galb1,4GlcbR) | Galc d18:1/18:1（GalaCeramide） | GM2Cer d18:1/24:1 (GalNAcb1,4(Neu5Aca2,3)Galb1,4GlcbCeramide) | GQ3Cer d20:1/24:1 (Neu5Aca2,8Neu5Aca2,8Neu5Aca2,8Neu5Aca2,3Galb1,4GlcbCeramide) | GT3Cer d18:1/18:0 (Neu5Aca2,8Neu5Aca2,8Neu5Aca2,3Galb1,4GlcbCeramide) | LacCer d18:1/18:0-Biotin (Galb1,4GlcbCeramide-Biotin) | GM1bCer d20:1/8:0 (Neu5Aca2,3Galb1,3GalNAcb1,4Galb1,4GlcbCeramide) | GM1bCer d18:1/24:1 (Neu5Aca2,3Galb1,3GalNAcb1,4Galb1,4GlcbCeramide) | FucGM1Cer d18:1/8:0 ((Fuca1,2)Galb1,3GalNAcb1,4(Neu5Aca2,3)Galb1,4GlcbCeramide) | GM3Cer d18:1/18:0 (Neu5Aca2,3Galb1,4GlcbCeramide) | GM1aCer d20:1/8:0 (Galb1,3GalNAcb1,4(Neu5Aca2,3)Galb1,4GlcbCeramide) | Sakuranin | GD2Cer d18:1/8:0 (GalNAcb1,4(Neu5Aca2,8Neu5Aca2,3)Galb1,4GlcbCeramide) | GQ3Cer d20:1/12:0 (Neu5Aca2,8Neu5Aca2,8Neu5Aca2,8Neu5Aca2,3Galb1,4GlcbCeramide) | GT1c | GD3Cer d20:1/20:0 (Neu5Aca2,8Neu5Aca2,3Galb1,4GlcbCeramide) | GM3sph d20:1 (Neu5Aca2,3Galb1,4GlcbSphingolipids) | FucGM1Cer d18:1/12:0 ((Fuca1,2)Galb1,3GalNAcb1,4(Neu5Aca2,3)Galb1,4GlcbCeramide) | GT1cCer d20:1/20:0 (Galb1,3GalNAcb1,4(Neu5Aca2,8Neu5Aca2,8Neu5Aca2,3)Galb1,4GlcbCeramide) | nLc4 | GM3Cer d18:1/18:0-Biotin ((Neu5Aca2,3)Galb1,4GlcbCeramide-Biotin) | SiaNAl | GD1aCer d18:1/20:0 ((Neu5Aca2,3)Galb1,3GalNAcb1,4(Neu5Aca2,3)Galb1,4GlcbCeramide) | GT3Cer d20:1/18:0 (Neu5Aca2,8Neu5Aca2,8Neu5Aca2,3Galb1,4GlcbCeramide) | GT3Cer d20:1/20:0 (Neu5Aca2,8Neu5Aca2,8Neu5Aca2,3Galb1,4GlcbCeramide) | iGloboHCer d18:1/18:0-Biotin ((Fuca1,2)Galb1,3GalNAcb1,3Gala1,3Galb1,4GlcbCeramide-Biotin) | GM3sph d18:1 (Neu5Aca2,3Galb1,4GlcbSphingolipids) | GT3Cer d18:1/18:0-Biotin (Neu5Aca2,8Neu5Aca2,8Neu5Aca2,3Galb1,4GlcbCeramide-Biotin) | Gluconapin | GT2Cer d18:1/8:0 (GalNAcb1,4(Neu5Aca2,8Neu5Aca2,8Neu5Aca2,3)Galb1,4GlcbCeramide) | GD1bCer d20:1/8:0 (Galb1,3GalNAcb1,4(Neu5Aca2,8Neu5Aca2,3)Galb1,4GlcbCeramide) | GT3Cer d18:1/18:0-Biotin (Neu5Aca2,8Neu5Aca2,8Neu5Aca2,3Galb1,4GlcbCeramide-Biotin) | GD1asph d18:1 ((Neu5Aca2,3)Galb1,3GalNAcb1,4(Neu5Aca2,3)Galb1 | SSEA-4 | GT3Cer d18:1/12:0 (Neu5Aca2,8Neu5Aca2,8Neu5Aca2,3Galb1,4GlcbCeramide) | GT2sph d20:1 (GalNAcb1,4(Neu5Aca2,8Neu5Aca2,8Neu5Aca2,3)Galb1,4GlcbSphingolipids) | H-Antigen-Cer d18:1/18:0-Biotin ((Fuca1,2)Galb1,4GlcbCeramide-Biotin) | GlcCer d20:1/16:0 (GlcbCeramide) | Blood type trisaccharide H Type III/IV | Neoglucobrassicin | BLewis Y (ALe Y) | Trifucosyllacto-N-hexaose | GD2Cer d20:1/24:1 (GalNAcb1,4(Neu5Aca2,8Neu5Aca2,3)Galb1,4GlcbCeramide) | GD1aCer d18:1/24:1 ((Neu5Aca2,3)Galb1,3GalNAcb1,4(Neu5Aca2,3)Galb1,4GlcbCeramide) | GT3sph d18:1 (Neu5Aca2,8Neu5Aca2,8Neu5Aca2,3Galb1,4GlcbSphingolipids) | GD1aCer d20:1/16:0 ((Neu5Aca2,3)Galb1,3GalNAcb1,4(Neu5Aca2,3)Galb1,4GlcbCeramide) | GD3Cer d20:1/24:1 (Neu5Aca2,8Neu5Aca2,3Galb1,4GlcbCeramide) | LacNAc PEG-NH2 | GQ3Cer d20:1/8:0 (Neu5Aca2,8Neu5Aca2,8Neu5Aca2,8Neu5Aca2,3Galb1,4GlcbCeramide) | Ac3 GlcNAcproN3 | GD1aCer d20:1/24:1 ((Neu5Aca2,3)Galb1,3GalNAcb1,4(Neu5Aca2,3)Galb1,4GlcbCeramide) | Ac4 ManNAc | Lc3 | GQ3Cer d18:1/20:0 (Neu5Aca2,8Neu5Aca2,8Neu5Aca2,8Neu5Aca2,3Galb1,4GlcbCeramide) | GalNAcb1, 3Gal | Lewis Y (Le Y) | GT1cCer d18:1/18:0 (Galb1,3GalNAcb1,4(Neu5Aca2,8Neu5Aca2,8Neu5Aca2,3)Galb1,4GlcbCeramide) | GT2 | GD1bCer d18:1/18:0-Biotin (Galb1,3GalNAcb1,4(Neu5Aca2,8Neu5Aca2,3)Galb1,4GlcbCeramide-Biotin) | GD1aCer d20:1/20:0 ((Neu5Aca2,3)Galb1,3GalNAcb1,4(Neu5Aca2,3)Galb1,4GlcbCeramide) |